CSI Market
Sign In | Register

Vaccinex Inc (VCNX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VCNX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Vaccinex Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent1.11
Cash & Short-term Investments1.00
Accounts receivable0.84
Derivative Asset, Current DE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.59
Total Current Assets2.53
Equipment/Property/Plant Net0.07
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets2.60
Liabilities
Accounts Payable, Current AC3.96
Accrued Liabilities, Current AC1.10
Derivative Liability, Current DE0.00
Long-term Debt, Current Maturities LO0.03
Other Liabilities, Current0.00
Total Current Liabilities5.08
Long-term debt0.00
Total Long-term Debt0.00
Operating Lease Liability Current-
Total Liabilities5.08
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock354.42
Retained Earnings / Accumulated Deficit-358.56
Other Equity0.00
Common Stockholder's Equity-4.15
Preferred Stockholder's Equity1.67
Total Stockholder's Equity-2.49
Liabilities & Stockholder's Equity2.60
4 historic quarters locked

Sign in to unlock the full Vaccinex Inc balance sheet history.

Sign In Create Free Account

About Vaccinex Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 14, 2024
  • Source: vcnx-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-127139

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.